nodes	percent_of_prediction	percent_of_DWPC	metapath
Diazoxide—CA1—Furosemide—dilated cardiomyopathy	0.41	0.536	CbGbCtD
Diazoxide—CA2—Furosemide—dilated cardiomyopathy	0.354	0.464	CbGbCtD
Diazoxide—KCNMA1—pulmonary artery—dilated cardiomyopathy	0.0192	0.383	CbGeAlD
Diazoxide—ABCC8—ATP sensitive Potassium channels—ABCC9—dilated cardiomyopathy	0.0189	0.202	CbGpPWpGaD
Diazoxide—KCNJ11—ATP sensitive Potassium channels—ABCC9—dilated cardiomyopathy	0.0184	0.196	CbGpPWpGaD
Diazoxide—ATP1A1—Ion transport by P-type ATPases—PLN—dilated cardiomyopathy	0.00452	0.0481	CbGpPWpGaD
Diazoxide—GLUL—myocardium—dilated cardiomyopathy	0.00404	0.0808	CbGeAlD
Diazoxide—ABCC8—Inwardly rectifying K+ channels—ABCC9—dilated cardiomyopathy	0.00368	0.0392	CbGpPWpGaD
Diazoxide—KCNJ11—Inwardly rectifying K+ channels—ABCC9—dilated cardiomyopathy	0.00357	0.038	CbGpPWpGaD
Diazoxide—ATP1A1—Preimplantation Embryo—NR3C2—dilated cardiomyopathy	0.00356	0.0379	CbGpPWpGaD
Diazoxide—Cerebral ischaemia—Lisinopril—dilated cardiomyopathy	0.00341	0.037	CcSEcCtD
Diazoxide—ABCC8—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00326	0.0348	CbGpPWpGaD
Diazoxide—Azotaemia—Lisinopril—dilated cardiomyopathy	0.00309	0.0336	CcSEcCtD
Diazoxide—GLUL—heart—dilated cardiomyopathy	0.00282	0.0564	CbGeAlD
Diazoxide—Glycosuria—Furosemide—dilated cardiomyopathy	0.00271	0.0294	CcSEcCtD
Diazoxide—KCNJ11—heart—dilated cardiomyopathy	0.00265	0.0529	CbGeAlD
Diazoxide—KCNMA1—heart—dilated cardiomyopathy	0.00262	0.0523	CbGeAlD
Diazoxide—ATP1A1—cardiac ventricle—dilated cardiomyopathy	0.00256	0.0512	CbGeAlD
Diazoxide—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00251	0.0272	CcSEcCtD
Diazoxide—ABCC8—heart—dilated cardiomyopathy	0.00244	0.0488	CbGeAlD
Diazoxide—ATP1A1—myocardium—dilated cardiomyopathy	0.00241	0.0482	CbGeAlD
Diazoxide—KCNMA1—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.00237	0.0253	CbGpPWpGaD
Diazoxide—Drug interaction—Furosemide—dilated cardiomyopathy	0.00237	0.0257	CcSEcCtD
Diazoxide—Gout—Furosemide—dilated cardiomyopathy	0.00235	0.0255	CcSEcCtD
Diazoxide—KCNMA1—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00204	0.0218	CbGpPWpGaD
Diazoxide—CA1—heart—dilated cardiomyopathy	0.00199	0.0397	CbGeAlD
Diazoxide—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00196	0.0213	CcSEcCtD
Diazoxide—CA2—cardiac ventricle—dilated cardiomyopathy	0.00196	0.0392	CbGeAlD
Diazoxide—CA2—myocardium—dilated cardiomyopathy	0.00185	0.0369	CbGeAlD
Diazoxide—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00178	0.0193	CcSEcCtD
Diazoxide—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00177	0.0193	CcSEcCtD
Diazoxide—Gout—Lisinopril—dilated cardiomyopathy	0.00176	0.0192	CcSEcCtD
Diazoxide—ATP1A1—heart—dilated cardiomyopathy	0.00168	0.0336	CbGeAlD
Diazoxide—Purpura—Furosemide—dilated cardiomyopathy	0.00165	0.018	CcSEcCtD
Diazoxide—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00164	0.0178	CcSEcCtD
Diazoxide—ATP1A1—Ion channel transport—RYR2—dilated cardiomyopathy	0.00161	0.0171	CbGpPWpGaD
Diazoxide—Malaise—Spironolactone—dilated cardiomyopathy	0.00159	0.0173	CcSEcCtD
Diazoxide—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00158	0.0171	CcSEcCtD
Diazoxide—ATP1A1—Ion channel transport—PLN—dilated cardiomyopathy	0.00156	0.0166	CbGpPWpGaD
Diazoxide—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00156	0.017	CcSEcCtD
Diazoxide—GLUL—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00155	0.0165	CbGpPWpGaD
Diazoxide—Discomfort—Spironolactone—dilated cardiomyopathy	0.00148	0.0161	CcSEcCtD
Diazoxide—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00147	0.016	CcSEcCtD
Diazoxide—ABCC8—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00145	0.0155	CbGpPWpGaD
Diazoxide—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00145	0.0158	CcSEcCtD
Diazoxide—ATP1A1—cardiac atrium—dilated cardiomyopathy	0.00144	0.0288	CbGeAlD
Diazoxide—KCNJ11—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00141	0.015	CbGpPWpGaD
Diazoxide—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00141	0.0153	CcSEcCtD
Diazoxide—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00136	0.0148	CcSEcCtD
Diazoxide—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00135	0.0147	CcSEcCtD
Diazoxide—CA2—heart—dilated cardiomyopathy	0.00129	0.0258	CbGeAlD
Diazoxide—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00124	0.0135	CcSEcCtD
Diazoxide—GLUL—Neuronal System—ABCC9—dilated cardiomyopathy	0.00124	0.0132	CbGpPWpGaD
Diazoxide—Diplopia—Lisinopril—dilated cardiomyopathy	0.00119	0.013	CcSEcCtD
Diazoxide—GLUL—Neuronal System—ACTN2—dilated cardiomyopathy	0.00119	0.0127	CbGpPWpGaD
Diazoxide—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00119	0.0129	CcSEcCtD
Diazoxide—Sweating—Furosemide—dilated cardiomyopathy	0.00118	0.0128	CcSEcCtD
Diazoxide—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00114	0.0124	CcSEcCtD
Diazoxide—CA2—cardiac atrium—dilated cardiomyopathy	0.0011	0.022	CbGeAlD
Diazoxide—SLC12A3—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00107	0.0114	CbGpPWpGaD
Diazoxide—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00106	0.0115	CcSEcCtD
Diazoxide—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00102	0.0111	CcSEcCtD
Diazoxide—Pruritus—Spironolactone—dilated cardiomyopathy	0.00102	0.0111	CcSEcCtD
Diazoxide—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00101	0.011	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—RAC1—dilated cardiomyopathy	0.000992	0.0106	CbGpPWpGaD
Diazoxide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000984	0.0107	CcSEcCtD
Diazoxide—Dizziness—Spironolactone—dilated cardiomyopathy	0.000951	0.0103	CcSEcCtD
Diazoxide—Weight increased—Lisinopril—dilated cardiomyopathy	0.00094	0.0102	CcSEcCtD
Diazoxide—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000932	0.0101	CcSEcCtD
Diazoxide—Vomiting—Spironolactone—dilated cardiomyopathy	0.000915	0.00994	CcSEcCtD
Diazoxide—Rash—Spironolactone—dilated cardiomyopathy	0.000907	0.00986	CcSEcCtD
Diazoxide—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000906	0.00985	CcSEcCtD
Diazoxide—Vision blurred—Furosemide—dilated cardiomyopathy	0.000904	0.00982	CcSEcCtD
Diazoxide—Headache—Spironolactone—dilated cardiomyopathy	0.000901	0.0098	CcSEcCtD
Diazoxide—KCNMA1—Neuronal System—ABCC9—dilated cardiomyopathy	0.000892	0.0095	CbGpPWpGaD
Diazoxide—Sweating—Lisinopril—dilated cardiomyopathy	0.000883	0.00959	CcSEcCtD
Diazoxide—Haematuria—Lisinopril—dilated cardiomyopathy	0.000878	0.00954	CcSEcCtD
Diazoxide—Leukopenia—Furosemide—dilated cardiomyopathy	0.000859	0.00933	CcSEcCtD
Diazoxide—KCNMA1—Neuronal System—ACTN2—dilated cardiomyopathy	0.000855	0.00911	CbGpPWpGaD
Diazoxide—Nausea—Spironolactone—dilated cardiomyopathy	0.000855	0.00929	CcSEcCtD
Diazoxide—Flushing—Lisinopril—dilated cardiomyopathy	0.000767	0.00834	CcSEcCtD
Diazoxide—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000766	0.00833	CcSEcCtD
Diazoxide—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000757	0.00822	CcSEcCtD
Diazoxide—Anorexia—Furosemide—dilated cardiomyopathy	0.000746	0.00811	CcSEcCtD
Diazoxide—Hypotension—Furosemide—dilated cardiomyopathy	0.000731	0.00795	CcSEcCtD
Diazoxide—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000703	0.00764	CcSEcCtD
Diazoxide—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00068	0.00739	CcSEcCtD
Diazoxide—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000678	0.00737	CcSEcCtD
Diazoxide—Pain—Furosemide—dilated cardiomyopathy	0.000669	0.00727	CcSEcCtD
Diazoxide—KCNJ11—Type II diabetes mellitus—TNF—dilated cardiomyopathy	0.000669	0.00712	CbGpPWpGaD
Diazoxide—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000668	0.00726	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—RAF1—dilated cardiomyopathy	0.000658	0.00701	CbGpPWpGaD
Diazoxide—Malaise—Lisinopril—dilated cardiomyopathy	0.000649	0.00705	CcSEcCtD
Diazoxide—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000645	0.00701	CcSEcCtD
Diazoxide—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000644	0.007	CcSEcCtD
Diazoxide—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00064	0.00696	CcSEcCtD
Diazoxide—Palpitations—Lisinopril—dilated cardiomyopathy	0.000636	0.00691	CcSEcCtD
Diazoxide—ABCC8—Neuronal System—ABCC9—dilated cardiomyopathy	0.000634	0.00676	CbGpPWpGaD
Diazoxide—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000619	0.00672	CcSEcCtD
Diazoxide—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000619	0.00672	CcSEcCtD
Diazoxide—KCNJ11—Neuronal System—ABCC9—dilated cardiomyopathy	0.000615	0.00655	CbGpPWpGaD
Diazoxide—Chest pain—Lisinopril—dilated cardiomyopathy	0.000613	0.00666	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—TTN—dilated cardiomyopathy	0.000613	0.00652	CbGpPWpGaD
Diazoxide—Anxiety—Lisinopril—dilated cardiomyopathy	0.000611	0.00664	CcSEcCtD
Diazoxide—ABCC8—Neuronal System—ACTN2—dilated cardiomyopathy	0.000608	0.00648	CbGpPWpGaD
Diazoxide—Discomfort—Lisinopril—dilated cardiomyopathy	0.000605	0.00658	CcSEcCtD
Diazoxide—KCNJ11—Neuronal System—ACTN2—dilated cardiomyopathy	0.00059	0.00628	CbGpPWpGaD
Diazoxide—Oedema—Lisinopril—dilated cardiomyopathy	0.000587	0.00638	CcSEcCtD
Diazoxide—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000577	0.00627	CcSEcCtD
Diazoxide—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000575	0.00625	CcSEcCtD
Diazoxide—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000573	0.00623	CcSEcCtD
Diazoxide—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000568	0.00617	CcSEcCtD
Diazoxide—Asthenia—Furosemide—dilated cardiomyopathy	0.000562	0.0061	CcSEcCtD
Diazoxide—Anorexia—Lisinopril—dilated cardiomyopathy	0.00056	0.00608	CcSEcCtD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000559	0.00596	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000559	0.00596	CbGpPWpGaD
Diazoxide—Pruritus—Furosemide—dilated cardiomyopathy	0.000554	0.00602	CcSEcCtD
Diazoxide—Hypotension—Lisinopril—dilated cardiomyopathy	0.000549	0.00596	CcSEcCtD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000544	0.00579	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000544	0.00579	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000544	0.00579	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000544	0.00579	CbGpPWpGaD
Diazoxide—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000536	0.00582	CcSEcCtD
Diazoxide—Insomnia—Lisinopril—dilated cardiomyopathy	0.000531	0.00577	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—ACTN2—dilated cardiomyopathy	0.000531	0.00566	CbGpPWpGaD
Diazoxide—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000527	0.00573	CcSEcCtD
Diazoxide—Dizziness—Furosemide—dilated cardiomyopathy	0.000518	0.00563	CcSEcCtD
Diazoxide—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000511	0.00555	CcSEcCtD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000506	0.00539	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000506	0.00539	CbGpPWpGaD
Diazoxide—Pain—Lisinopril—dilated cardiomyopathy	0.000502	0.00546	CcSEcCtD
Diazoxide—Vomiting—Furosemide—dilated cardiomyopathy	0.000498	0.00541	CcSEcCtD
Diazoxide—Rash—Furosemide—dilated cardiomyopathy	0.000494	0.00536	CcSEcCtD
Diazoxide—Dermatitis—Furosemide—dilated cardiomyopathy	0.000493	0.00536	CcSEcCtD
Diazoxide—Headache—Furosemide—dilated cardiomyopathy	0.00049	0.00533	CcSEcCtD
Diazoxide—GLUL—Metabolism—ANKRD1—dilated cardiomyopathy	0.000485	0.00517	CbGpPWpGaD
Diazoxide—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000484	0.00526	CcSEcCtD
Diazoxide—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00048	0.00522	CcSEcCtD
Diazoxide—Nausea—Furosemide—dilated cardiomyopathy	0.000465	0.00505	CcSEcCtD
Diazoxide—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000464	0.00505	CcSEcCtD
Diazoxide—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000464	0.00505	CcSEcCtD
Diazoxide—GLUL—Metabolism—TAZ—dilated cardiomyopathy	0.000456	0.00486	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—VCL—dilated cardiomyopathy	0.000452	0.00481	CbGpPWpGaD
Diazoxide—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000433	0.0047	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—TNF—dilated cardiomyopathy	0.00043	0.00458	CbGpPWpGaD
Diazoxide—Asthenia—Lisinopril—dilated cardiomyopathy	0.000421	0.00458	CcSEcCtD
Diazoxide—Pruritus—Lisinopril—dilated cardiomyopathy	0.000416	0.00452	CcSEcCtD
Diazoxide—GLUL—Metabolism—SDHA—dilated cardiomyopathy	0.000412	0.00439	CbGpPWpGaD
Diazoxide—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000402	0.00437	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000389	0.00414	CbGpPWpGaD
Diazoxide—Dizziness—Lisinopril—dilated cardiomyopathy	0.000388	0.00422	CcSEcCtD
Diazoxide—ABCC8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000377	0.00402	CbGpPWpGaD
Diazoxide—Vomiting—Lisinopril—dilated cardiomyopathy	0.000373	0.00406	CcSEcCtD
Diazoxide—Rash—Lisinopril—dilated cardiomyopathy	0.00037	0.00402	CcSEcCtD
Diazoxide—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00037	0.00402	CcSEcCtD
Diazoxide—Headache—Lisinopril—dilated cardiomyopathy	0.000368	0.004	CcSEcCtD
Diazoxide—ABCC8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000367	0.00391	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000367	0.00391	CbGpPWpGaD
Diazoxide—GLUL—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000353	0.00376	CbGpPWpGaD
Diazoxide—Nausea—Lisinopril—dilated cardiomyopathy	0.000349	0.00379	CcSEcCtD
Diazoxide—ABCC8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000341	0.00363	CbGpPWpGaD
Diazoxide—ATP1A1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000317	0.00338	CbGpPWpGaD
Diazoxide—CA2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000304	0.00324	CbGpPWpGaD
Diazoxide—CA1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000292	0.00311	CbGpPWpGaD
Diazoxide—CA2—Metabolism—TAZ—dilated cardiomyopathy	0.000286	0.00305	CbGpPWpGaD
Diazoxide—CA1—Metabolism—TAZ—dilated cardiomyopathy	0.000274	0.00292	CbGpPWpGaD
Diazoxide—GLUL—Neuronal System—RAF1—dilated cardiomyopathy	0.000271	0.00288	CbGpPWpGaD
Diazoxide—CA2—Metabolism—SDHA—dilated cardiomyopathy	0.000259	0.00275	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—ANKRD1—dilated cardiomyopathy	0.000248	0.00264	CbGpPWpGaD
Diazoxide—CA1—Metabolism—SDHA—dilated cardiomyopathy	0.000248	0.00264	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—ANKRD1—dilated cardiomyopathy	0.00024	0.00256	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—TAZ—dilated cardiomyopathy	0.000233	0.00248	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—ITGB1—dilated cardiomyopathy	0.000227	0.00241	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—TAZ—dilated cardiomyopathy	0.000226	0.00241	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—SDHA—dilated cardiomyopathy	0.000211	0.00224	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—SDHA—dilated cardiomyopathy	0.000204	0.00218	CbGpPWpGaD
Diazoxide—KCNMA1—Neuronal System—RAF1—dilated cardiomyopathy	0.000195	0.00207	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—CD36—dilated cardiomyopathy	0.000193	0.00206	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—RAC1—dilated cardiomyopathy	0.000182	0.00194	CbGpPWpGaD
Diazoxide—ABCC8—Neuronal System—RAF1—dilated cardiomyopathy	0.000138	0.00147	CbGpPWpGaD
Diazoxide—KCNJ11—Neuronal System—RAF1—dilated cardiomyopathy	0.000134	0.00143	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—RAF1—dilated cardiomyopathy	0.000121	0.00129	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—GPX1—dilated cardiomyopathy	0.000112	0.00119	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.00011	0.00118	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.00011	0.00118	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—CD36—dilated cardiomyopathy	0.000109	0.00116	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—AGT—dilated cardiomyopathy	9.83e-05	0.00105	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.44e-05	0.000792	CbGpPWpGaD
Diazoxide—CA2—Metabolism—GPX1—dilated cardiomyopathy	7.02e-05	0.000748	CbGpPWpGaD
Diazoxide—CA2—Metabolism—CD36—dilated cardiomyopathy	6.84e-05	0.000729	CbGpPWpGaD
Diazoxide—CA1—Metabolism—GPX1—dilated cardiomyopathy	6.73e-05	0.000717	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CD36—dilated cardiomyopathy	6.56e-05	0.000698	CbGpPWpGaD
Diazoxide—CA2—Metabolism—AGT—dilated cardiomyopathy	6.16e-05	0.000656	CbGpPWpGaD
Diazoxide—CA1—Metabolism—AGT—dilated cardiomyopathy	5.9e-05	0.000629	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GPX1—dilated cardiomyopathy	5.73e-05	0.00061	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CD36—dilated cardiomyopathy	5.58e-05	0.000594	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GPX1—dilated cardiomyopathy	5.55e-05	0.000591	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CD36—dilated cardiomyopathy	5.41e-05	0.000576	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—AGT—dilated cardiomyopathy	5.02e-05	0.000535	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—AGT—dilated cardiomyopathy	4.87e-05	0.000519	CbGpPWpGaD
